OncoZenge AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	99	85	44	36	64	135
Market Cap Growth	54.51%	94.64%	21.36%	-43.82%	-52.42%	-
Enterprise Value	106	81	38	20	32	80
Last Close Price	7.06	6.76	3.75	3.09	5.50	11.56
PS Ratio	1396.89	30.71	43924.67	12064.64	-	-
PB Ratio	277.04	10.09	4.42	1.94	1.90	1.69
P/TBV Ratio	-	52.55	14.17	3.07	2.38	1.84
EV/Sales Ratio	-	29.24	38094.67	6750.97	-	-
EV/EBITDA Ratio	-	-	-	2.79	11.43	-
Debt / Equity Ratio	20.95	0.89	-	-	-	-
Net Debt / Equity Ratio	18.34	0.45	-0.39	-0.68	-0.86	-0.64
Net Debt / EBITDA Ratio	-	-	-	-1.74	-10.53	-
Asset Turnover	0.01	0.16	0	0	-	-
Quick Ratio	0.69	0.74	2.95	7.81	10.22	10.62
Current Ratio	1.26	1.01	3.09	7.94	10.29	10.63
Return on Equity (ROE)	-446.60%	-173.01%	-60.77%	-60.45%	-81.62%	-7.09%
Return on Assets (ROA)	-120.16%	-55.07%	-34.17%	-34.73%	-20.88%	-4.95%
Return on Capital Employed (ROCE)	-288.00%	-98.80%	-87.30%	-85.30%	-60.10%	-6.10%
Earnings Yield	-23.31%	-18.64%	-19.78%	-43.94%	-72.41%	-2.87%
Buyback Yield / Dilution	-6.89%	-3.56%	-	-	0.53%	-